Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Waterhouse

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Hospital|May 30, 2018
The Harrow Cottage Hospital: Its Architecture and Its CriticsPaul Waterhouse
Nature Reviews. Cancer|December 10, 2016
TIMPs: versatile extracellular regulators in cancerHartland W Jackson, Virginie Defamie, Paul Waterhouse, et al.
Nature Cell Biology|February 24, 2015
Expansion of stem cells counteracts age-related mammary regression in compound Timp1/Timp3 null miceHartland W Jackson, Paul Waterhouse, Ankit Sinha, et al.
Science Translational Medicine|December 15, 2015
RANKL blockade prevents and treats aggressive osteosarcomasYan Chen, Marco A Di Grappa, Sam D Molyneux, et al.
The Prostate|September 3, 2015
Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancerHibret A Adissu, Colin McKerlie, Marco Di Grappa, et al.
Cancer Letters|September 18, 2025
The histone lysine methyltransferase NSD3 drives osteosarcomagenesis by inactivating ARID3AJinchang Lu, Yang Shao, Sanjay Saw, et al.
The Journal of Biological Chemistry|May 9, 2025
Extent of N-glycosylation of the metalloproteinase inhibitor and cytokine TIMP-1 determines pancreatic cancer cell proliferation and survival via CD63Daniel Häußler, Damjan Manevski, Julian Frädrich, et al.
Oncogene|August 11, 2018
Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcomaYang W Shao, Geoffrey A Wood, Jinchang Lu, et al.
The Journal of Cell Biology|June 21, 2018
Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilitiesAlison E Casey, Ankit Sinha, Rajat Singhania, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Hospital|May 30, 2018
The Harrow Cottage Hospital: Its Architecture and Its CriticsPaul Waterhouse
Nature Reviews. Cancer|December 10, 2016
TIMPs: versatile extracellular regulators in cancerHartland W Jackson, Virginie Defamie, Paul Waterhouse, et al.
Nature Cell Biology|February 24, 2015
Expansion of stem cells counteracts age-related mammary regression in compound Timp1/Timp3 null miceHartland W Jackson, Paul Waterhouse, Ankit Sinha, et al.
Science Translational Medicine|December 15, 2015
RANKL blockade prevents and treats aggressive osteosarcomasYan Chen, Marco A Di Grappa, Sam D Molyneux, et al.
The Prostate|September 3, 2015
Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancerHibret A Adissu, Colin McKerlie, Marco Di Grappa, et al.
Cancer Letters|September 18, 2025
The histone lysine methyltransferase NSD3 drives osteosarcomagenesis by inactivating ARID3AJinchang Lu, Yang Shao, Sanjay Saw, et al.
The Journal of Biological Chemistry|May 9, 2025
Extent of N-glycosylation of the metalloproteinase inhibitor and cytokine TIMP-1 determines pancreatic cancer cell proliferation and survival via CD63Daniel Häußler, Damjan Manevski, Julian Frädrich, et al.
Oncogene|August 11, 2018
Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcomaYang W Shao, Geoffrey A Wood, Jinchang Lu, et al.
The Journal of Cell Biology|June 21, 2018
Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilitiesAlison E Casey, Ankit Sinha, Rajat Singhania, et al.
Pageof 1